atezolizumab,bevacizumab
roche
[]
fortunate to receive a merit award for some of our work on etiology of hcc and outcomes with first line atezo/bev #gi23 
Fellow @PennCancer. @NIH_LRP.  @PC3Innovation. MSCE Student. GI Cancers. Former @UTSWIMchief. Lucas’ dad forever. Views own. ASCO FCOI https://t.co/rmHB23k0Ph